Efficacy and Safety of Rivaroxaban in the Early Postoperative Period for Patients With Bioprosthetic Valves
Clinical trial NCT06476301 · NOT_YET_RECRUITING
Trial details
- NCT number
- NCT06476301
- Sponsor
- RenJi Hospital
- Status
- NOT_YET_RECRUITING
- Phase
- Phase 4
- Study type
- INTERVENTIONAL
- Start date
- 2024-08-01
- Primary completion
- 2026-02-28
- Enrollment
- 250
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.